Inflammation

Latest News

COPD graphic | Image Credit: Maks_Lab - stock.adobe.com
Systemic Immune Response Index Identified as Independent Risk Factor for COPD

March 23rd 2025

The systemic immune response index outperformed other inflammatory markers in predicting chronic obstructive pulmonary disease (COPD).

Hemoglobin structure | Image Credit: Andrea Danti - stock.adobe.com
Hemoglobin May Protect Against Inflammation From Rheumatoid Arthritis

March 20th 2025

Food rich in fiber | Image Credit: photka - stock.abode.com
Higher Dietary Fiber Intake Associated With Lower Osteoarthritis Risk

March 9th 2025

Older White male exercising | Image Credit: Halfpoint - stock.adobe.com
RA-Specific Physical Activity Resources Provide Guidance but Need Improvement

February 26th 2025

Hands holding paper bladder | Image Credit: SewcreamStudio - stock.adobe.com
Findings Suggest Potential Link Between Overactive Bladder, Osteoarthritis

February 13th 2025

Recommended Guidelines and Restrictions in Asthma

Defining the recommended guidelines and the formulary restrictions with the standard of care for asthma.

Use of Biologics for the Treatment of Asthma panelists
Continuing Medical Education
View All
March 31st 2025

Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know

1.5 Credits / Immunology, Allergy
March 31st 2025

Exploring Innovative Approaches in Myasthenia Gravis and the Specialty Pharmacist’s Role in Optimizing Value-Based Treatment

1.5 Credits / Immunology
March 31st 2025

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology
March 31st 2025

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Immunology, Neurology
March 31st 2025

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases
March 31st 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
March 31st 2025

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology
March 31st 2025

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

1.5 Credits / Allergy, Immunology

More News

Asthma word graphic
August 12th 2021

Occupational Asthma More Likely to Be Delayed, Missed

Lauren Massaro
Many intrinsic and extrinsic factors hinder primary health care professionals from identifying a patient as having occupational asthma.
William "Andy" Nish, MD
August 7th 2021

Dr William "Andy" Nish Debunks Common Reasons for Not Getting COVID-19 Vaccine

Getting vaccinated is important to protect yourself, your family, and your community, says William "Andy" Nish, MD, an allergist and immunologist at Northeast Georgia Physicians Group.
Scale
August 6th 2021

Model Suggests Body Weight Affects Dupilumab Pharmacokinetics in Patients With Asthma

Jared Kaltwasser
Although body weight affected pharmacokinetics, the investigators said dosing adjustments based on weight were not warranted.
Dr William "Andy" Nish on When a Patient With Asthma Should Start a Biologic
July 31st 2021

Dr William "Andy" Nish on When a Patient With Asthma Should Start a Biologic

William "Andy" Nish, MD, an allergist and immunologist at Northeast Georgia Physicians Group, discusses the factors that influence whether patients with asthma should be prescribed a biologic therapy.
COVID-19 Sparks Drop in In-Person Visits, Spike in Telehealth Among Children With Asthma
July 28th 2021

COVID-19 Sparks Drop in In-Person Visits, Spike in Telehealth Among Children With Asthma

Jared Kaltwasser
Data suggest asthma exacerbations dropped for children and adolescents during the pandemic, and most families chose to use telehealth services when available.
Study Links Asthmatic Inflammation to Viral Infection Response
July 24th 2021

Study Links Asthmatic Inflammation to Viral Infection Response

Jared Kaltwasser
Viral infections can induce asthma exacerbations, but a report finds the inflammation itself can also have an impact on the infection.
Child using nebulizer
July 21st 2021

Particulate Matter Concentration Linked With Pediatric Asthma Hospital Visits

Jared Kaltwasser
When particulate matter concentrations were high, patients were more likely to experience asthma exacerbations and likely were also more likely to have reactions to house dust mites.
COVID-19 ball
July 13th 2021

Systemic Corticosteroids, but Not Biologics, Worsen COVID-19 Outcomes in Patients With Asthma

Jared Kaltwasser
The more often a patient used systemic corticosteroids, the higher their risk of moderate or severe COVID-19 and all-cause mortality, the study found.
inhalers
July 9th 2021

Anaphylaxis Risk Varies Among Monoclonal Antibodies in Patients With Severe Asthma

Jared Kaltwasser
New research based on real-world data largely aligns with the scientific literature, although one monoclonal antibody—dupilumab—stood out for its very low risk.
Lawrence Eichenfield, MD
June 30th 2021

Dr Lawrence F. Eichenfield Describes the Differences Between Treating Adult vs Pediatric Patients With AD

Pediatric patients with atopic dermatitis (AD) often vary in disease severity and it can be difficult to assess how much of a topical therapy is needed, said Lawrence F. Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego.
Atopic dermatitis research
June 26th 2021

Review Finds Several AD Treatment Options, More to Come

Jared Kaltwasser
A handful of systemic therapies can be prescribed off label to effectively treat atopic dermatitis (AD), but investigators said a biologic option may be best for many patients.
doctor writing on clipboard while listening to a patient talk
June 25th 2021

Inflammation Review: FDA Approves New Dupixent Dose, Probiotic Mixture Proves Effective for AD, and More

Skylar Jeremias
Highlighting the latest inflammation-related news reported across MJH Life Sciences™.
child receiving a vaccine
June 18th 2021

Expert Panel Makes 7 Recommendations for Vaccinations for Children With AD Receiving Dupilumab

Skylar Jeremias
A panel of health care professionals reviewed published literature to develop a recommendation guide to advise providers on best practices when considering vaccinations for children with atopic dermatitis (AD) on dupilumab.
AD Patients Most Satisfied With Group-Based Educational Sessions
June 9th 2021

AD Patients Most Satisfied With Group-Based Educational Sessions

Jared Kaltwasser
Patients with atopic dermatitis (AD) benefit from extensive patient education. A new report suggests group-based sessions are preferred to individual educational sessions or fun activities.
blood cells
June 3rd 2021

Study Explores Circulating Biomarker Profiles of Patients With Atopic Dermatitis

Jared Kaltwasser
Existing research has focused on skin symptoms, but a new study looks for alterations in the blood associated with moderate-to-severe atopic dermatitis.
needles
May 25th 2021

Dupilumab Improves Work Quality of Life in Patients With AD

Jared Kaltwasser
A new report shows work-related quality of life in general—and also in terms of physical and mental/emotional health—improved when patients began treatment for atopic dermatitis.
Jonathan Silverberg, MD, PhD, MPH
May 21st 2021

Dr Jonathan Silverberg Discusses What Future Research on AD in Children Should Include

Now that racial and ethnic disparities of atopic dermatitis prevalence among children have been confirmed, the next step in research will be to discover the reasons why those disparities exist, said Jonathan Silverberg, MD, PhD, MPH.
child's hand holding an adult's
May 19th 2021

Childhood AD Affects Educational Outcomes, New Analysis Finds

Jared Kaltwasser
Children with severe atopic dermatitis, in particular, were less likely than a control group to complete education at all levels, from basic compulsory education to postgraduate education.
Jonathan Silverberg, MD, PhD, MPH
May 14th 2021

Dr Jonathan Silverberg Sheds Light on the Shift in Comorbidities Associated With Atopic Dermatitis

In order to properly help patients manage their disease, it is critical for clinicians to recognize the differences in prevalence, severity, and persistency of atopic dermatitis among different demographics, said Jonathan Silverberg, MD, PhD, MPH.
asthma inhaler
May 12th 2021

Asthma Exacerbations Declined Among Black and Hispanic Patients During COVID-19

Laura Joszt, MA
Asthma exacerbations among Black/African American and Hispanic/Latinx adults with moderate-to-severe asthma decreased by approximately 40% during the COVID-19 pandemic, particularly among individuals who worked outside the home and those without type 2 inflammation.
evaluating dupilumab in a value based health plan
May 10th 2021

Evaluating Dupilumab for Placement in a Value-Based Health Plan

Larry Hanover
Dupilumab is effective for atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, but a recent presentation noted the payer challenge in placing the biologic in an optimal tier.
Jonathan Silverberg, MD, PhD, MPH
May 7th 2021

Dr Jonathan Silverberg Explains the Steady Increase in Atopic Dermatitis Among Children

As the population continues to diversify, the United States may be headed for increases in atopic dermatitis disease burden among children, said Jonathan Silverberg, MD, PhD, MPH.
Dr Jonathan Silverberg on Why It's Crucial to Know How AD Prevalence Shifts Over Time
April 30th 2021

Dr Jonathan Silverberg on Why It's Crucial to Know How AD Prevalence Shifts Over Time

As atopic dermatitis (AD) prevalence has increased in children over several decades, it's critical for physicians to recognize the environmental and demographic factors contributing to the change, said Jonathan Silverberg, MD, PhD, MPH.
Atopic Diseases Linked to Behavioral Difficulties in Children, Adolescents
April 29th 2021

Atopic Diseases Linked to Behavioral Difficulties in Children, Adolescents

Jaime Rosenberg
The study findings show that atopic dermatitis is associated with internalizing and externalizing problems, with younger children experiencing emotional problems and adolescents with other atopic diseases having relationship problems.
children with backpacks smiling
April 15th 2021

Examining the Link Between AD Severity, Learning Disorders Among Children

Gianna Melillo
Data from a recent cross-sectional study show severity of atopic dermatitis (AD) is associated with prevalence of learning disorders among children.
Gut microbiota
April 10th 2021

Researchers Tie Gut Microbiota and IL-17 Variants to AD in Infants

Jaime Rosenberg
According to the researchers, the study is the first to describe a relationship between these factors and the development of atopic dermatitis (AD) in infants using multiomics.
Measuring chemical levels
March 30th 2021

Formaldehyde Linked to Symptom Exacerbation Among Children With AD, Study Says

Larry Hanover
Exposure to indoor formaldehyde can exacerbate atopic dermatitis (AD) symptoms in children with moderate to severe disease, especially in spring and summer and even at allowable levels.
Child using inhaler for asthma
March 25th 2021

Machine Learning Can Help Predict Persistence of Asthma as Children Age

Larry Hanover
Machine learning models can help predict which children diagnosed with childhood asthma before age 5 will continue to experience symptoms as they get older.
Convolutional Neural Networks Can Determine AD Severity
March 20th 2021

Convolutional Neural Networks Can Determine AD Severity

Allison Inserro
Deep learning algorithms to diagnose skin disease like atopic dermatitis could save time for providers while increasing accuracy, according to a pilot study.
How Do Gut Microbiota Differ by Inflammatory Atopic Diseases?
March 19th 2021

How Do Gut Microbiota Differ by Inflammatory Atopic Diseases?

AJMC Staff
Recent findings indicate that the symptoms of atopic dermatitis, hives, and rhinitis can all be linked to specific microbiota, implying that the gut-skin axis and gut-nose axis do exist.
<1
...
4567891011>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo